InvestSMART

EBOS Group Limited (ASX:EBO)

ALERT: Price-sensitive ASX Announcement for EBO
Current share price for EBO : $17.980 -2.12 (-10.55%)+
Announcement
Release
25 Feb 2026 7:33AM
Price at Release
$20.100
Full Release
download
Summary
The interim report for EBOS Group Limited highlights robust revenue growth of 13.0% to $6.8 billion and substantial progress in capital investments. The company's underlying EBITDA increased by 3.2% to $300 million, with significant contributions from both the Healthcare and Animal Care segments. EBOS successfully progressed its distribution centre renewal program, enhancing operational efficiency and preparing for future growth. The company completed strategic acquisitions, expanding its capabilities in Animal Care, Medical Technology, and Retail Pharmacy, which are expected to drive future revenue and EPS growth. EBOS maintains a strong capital management approach, with refinanced debt facilities providing liquidity support. The directors declared an interim dividend of NZ 57.0 cents per share, reflecting confidence in the group's ongoing growth trajectory and cash flow strength. The near-term outlook remains positive, with expectations for continued revenue momentum and operational leverage improvements as new assets stabilize.
Key Points
  • EBOS reported strong revenue growth of 13.0% to $6.8 billion.
  • Underlying EBITDA increased by 3.2% to $300 million.
  • Distribution centre renewal program is nearing completion, enhancing efficiency.
  • Strategic acquisitions in Animal Care, Medical Technology, and Retail Pharmacy sectors.
  • Interim dividend declared at NZ 57.0 cents per share.
  • Positive outlook for continued revenue growth and efficiency gains.
  • Refinanced debt facilities to support liquidity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.